Volume 3, Issue 3, Page 7 (March 2007)
8 of 34
PREVIEW
FULL TEXT
FULL-TEXT PDF (62 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
The Food and Drug Administration has told eight manufacturers and 12 distributors of unapproved ergotamine-containing drugs to stop marketing these products because of concerns about inadequate safety labeling.
PII: S1553-3212(07)70074-2
doi:10.1016/S1553-3212(07)70074-2
© 2007 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
PREVIEW